Life Sciences: What's Next?

Working with Savills, we’ve looked at the companies merging new technologies with research developments in UK life sciences.

Life Sciences: What’s Next? cover

Inside this free report, you’ll find out:

  • The prevalence of academic spinouts in the UK’s life sciences industry
  • How much equity investment and grant funding is being secured by high-growth life sciences companies
  • The important sub-sectors of life sciences, with deep dives into AI drug discovery, vaccines, healthtech, microbiome-based therapies, immunotherapy, and cell and gene therapy

Here’s a sneak peek inside

Life Sciences: What’s Next? — map of high-growth life science companiesLife Sciences: What’s Next? — grants and spinouts

About the authors

More leads, more clients, less churn.

Get access to unrivalled data on all the companies you need to know about, so you can approach the right leads, at the right time.

Book a demo today to see all of the key features, as well as the depth and breadth of data available on the Beauhurst platform.

An associate will work with you to build a sophisticated search, returning a dynamic list of organisations matching your ideal client profile.